LIfT BioSciences has received a significant investment in its mission to develop the first curative and affordable cell therapy for all...

LIfT BioSciences has been awarded Best Rising Start-Up at BioVaria 2018 by the experienced panel of judges, comprised of major Pharma...

LIfT BioSciences has successfully raised £300K in seed funding to help complete their cutting-edge laboratory work towards developing the...

Read full article here - Note: An inaccuracy in this article is that LIfT will use survivor donor cells. We will be recruiting donors...

Early-stage research has shown that cancer cells from a well-known human cancer cell line (HeLa cells) can be killed by human neutrophils...